Acquisition - November 4, 2014
LabCorp to Acquire Covance
Laboratory Corporation of America (LH), also known as LabCorp, plans to acquire Covance (CVD) for $6.1 billion. Covance, a CRO that provides services for drug development and animal testing, is based in Princeton, NJ (US). LabCorp is the second largest clinical diagnostic company in the U.S. Acquiring Covance will help LabCorp access a larger international […]
Clinical Trials - November 4, 2014
Ebola Nasal Vaccine Trials
Researchers at the University of Texas at Austin have a nasal vaccine for the Ebola virus in development that has provided long-term protection for non-human primates against the virus. Small pre-clinical study results are the first to show that a single dose of a non-injectable vaccine for Ebola could have a longer duration. The research […]
Pharma Business - November 4, 2014
Orphan Drugs’ Market Share to Increase
Interest in developing drugs for orphan diseases is expected to grow into the next decade, leading to orphan drugs making up 19 percent of all prescription sales by 2020, according to some estimates. Sales also could increase at a rate of almost 11 percent per year through the end of the decade, almost three times […]
